Neuronal protein trafficking associated with Alzheimer disease

References

• Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366:2112 - 2117
   PubMed Web of Science ®Google Scholar
• Goedert M, Ghetti B. Alois Alzheimer: his life and times. Brain Pathol 2007; 17:57 - 62
   PubMed Web of Science ®Google Scholar
• Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006; 314:777 - 781
   PubMed Web of Science ®Google Scholar
• Hardy J. A hundred years of Alzheimer's disease research. Neuron 2006; 52:3 - 13
   PubMed Web of Science ®Google Scholar
• Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, et al. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 2005; 1739:198 - 210
   PubMed Web of Science ®Google Scholar
• Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120:885 - 890
   PubMed Web of Science ®Google Scholar
• Masters CL, Simms G, Weinman NA, Multhaup G, McDonald B, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985; 82:4245 - 4249
   PubMed Web of Science ®Google Scholar
• Blurton-Jones M, Laferla FM. Pathways by which Aβ facilitates tau pathology. Curr Alzheimer Res 2006; 3:437 - 448
   PubMedGoogle Scholar
• King ME, Kan HM, Baas PW, Erisir A, Glabe CG, Bloom GS. Tau-dependent microtubule disassembly initiated by prefibrillar β-amyloid. J Cell Biol 2006; 175:541 - 546
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002; 297:353 - 356
   PubMed Web of Science ®Google Scholar
• Lee HG, Casadesus G, Zhu X, Joseph JA, Perry G, Smithm MA. Perspectives on the amyloid-β cascade hypothesis. J Alzheimers Dis 2004; 6:137 - 145
   PubMed Web of Science ®Google Scholar
• Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature 2006; 440:352 - 357
   PubMed Web of Science ®Google Scholar
• Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 2005; 8:79 - 84
   PubMed Web of Science ®Google Scholar
• Hoozemans JJ, Chafekar SM, Baas F, Eikelenboom P, Scheper W. Always around, never the same: pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease. Curr Med Chem 2006; 13:2599 - 2605
   PubMed Web of Science ®Google Scholar
• Wirths O, Multhaup G, Bayer TA. A modified β-amyloid hypothesis: intraneuronal accumulation of the β-amyloid peptide—the first step of a fatal cascade. J Neurochem 2004; 91:513 - 520
   PubMed Web of Science ®Google Scholar
• Cuello AC. Intracellular and extracellular Aβ, a tale of two neuropathologies. Brain Pathol 2005; 15:66 - 71
   PubMed Web of Science ®Google Scholar
• LaFerla FM, Green KN, Oddo S. Intracellular amyloid-β in Alzheimer's disease. Nat Rev Neurosci 2007; 8:499 - 509
   PubMed Web of Science ®Google Scholar
• Haass C. Take five—BACE1 and the γ-secretase quartet conduct Alzheimer's amyloid β-peptide generation. EMBO J 2004; 23:483 - 488
   PubMed Web of Science ®Google Scholar
• Wilquet V, De Strooper B. Amyloid-beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol 2004; 14:582 - 588
   PubMed Web of Science ®Google Scholar
• Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE1. Science 1999; 286:735 - 741
   PubMed Web of Science ®Google Scholar
• Vassar R. BACE1: the β-secretase enzyme in Alzheimer's disease. J Mol Neurosci 2004; 23:105 - 114
   PubMed Web of Science ®Google Scholar
• Zhang Y, McLaughlin R, Goodyear C, LeBlanc A. Selective cytotoxicity of intracellular amyloid-β peptide 1–42 through p53 and Bax in cultured primary human neurons. J Cell Biol 2002; 156:519 - 529
   PubMed Web of Science ®Google Scholar
• Kim W, Hecht MH. Sequence determinants of enhanced amyloidogenicity of Alzheimer Aβ42 peptide relative to Aβ40. J Biol Chem 2005; 280:35069 - 35076
   PubMed Web of Science ®Google Scholar
• Awasthi A, Matsunaga Y, Yamada T. Amyloid-β causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-β-derived short peptides. Exp Neurol 2005; 196:282 - 289
   PubMed Web of Science ®Google Scholar
• Zou K, Kim D, Kakio A, Byun K, Gong JS, Kim J, et al. Amyloid β-protein (Aβ)1–40 protects neurons from damage induced by Aβ1-42 in culture and in the brain. J Neurochem 2003; 87:609 - 619
   PubMed Web of Science ®Google Scholar
• Yan Y, Wang C. Aβ40 protects non-toxic Abeta42 monomer from aggregation. J Mol Biol 2007; 369:909 - 916
   PubMed Web of Science ®Google Scholar
• Allinson TM, Parkin ET, Turner AJ, Hooper NM. ADAMs family members as amyloid precursor protein α-secretases. J Neurosci Res 2003; 74:342 - 352
   PubMed Web of Science ®Google Scholar
• Mattson MP. Secreted forms of β-amyloid precursor protein modulate dendritic outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J Neurobiol 1994; 25:439 - 450
   PubMedGoogle Scholar
• Meziane H, Dodart JC, Mathis C, Little S, Clemens J, Paul SM, et al. Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci USA 1998; 95:12683 - 12688
   PubMed Web of Science ®Google Scholar
• Tang BL. Alzheimer's disease: channeling APP to non-amyloidogenic processing. Biochem Biophys Res Commun 2005; 331:375 - 378
   PubMed Web of Science ®Google Scholar
• Fahrenholz F, Postina R. Alpha-secretase activation—an approach to Alzheimer's disease therapy. Neurodegener Dis 2006; 3:255 - 261
   PubMed Web of Science ®Google Scholar
• Kopan R, Ilagan MX. Gamma-secretase: proteasome of the membrane?. Nat Rev Mol Cell Biol 2004; 5:499 - 504
   PubMed Web of Science ®Google Scholar
• Brown MS, Ye J, Rawson RB, Goldstein JL. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 2000; 100:391 - 398
   PubMed Web of Science ®Google Scholar
• Weihofen A, Martoglio B. Intramembrane-cleaving proteases: Controlled liberation of functional proteins and peptides from membranes. Trends Cell Biol 2003; 13:71 - 78
   PubMed Web of Science ®Google Scholar
• Selkoe D, Kopan R. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 2003; 26:565 - 597
   PubMed Web of Science ®Google Scholar
• Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, et al. A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 2002; 2:1948 - 1956
   Web of Science ®Google Scholar
• Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 1999; 398:513 - 517
   PubMed Web of Science ®Google Scholar
• De Strooper B. Aph-1, Pen-2 and nicastrin with presenilin generate an active γ-secretase complex. Neuron 2003; 38:9 - 12
   PubMed Web of Science ®Google Scholar
• Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, Haass C. Reconstitution of γ-secretase activity. Nat Cell Biol 2003; 5:486 - 488
   PubMed Web of Science ®Google Scholar
• Chen F, Hasegawa H, Schmitt-Ulms G, Kawarai T, Bohm C, Katayama T, et al. TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity. Nature 2006; 440:1208 - 1212
   PubMed Web of Science ®Google Scholar
• Cao X, Sudhof TC. Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J Biol Chem 2004; 279:24601 - 24611
   PubMed Web of Science ®Google Scholar
• Von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM, et al. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci 2004; 117:4435 - 4448
   PubMed Web of Science ®Google Scholar
• Galvan V, Chen S, Lu D, Logvinova A, Goldsmith P, Koo EH, et al. Caspase cleavage of members of the amyloid precursor family of proteins. J Neurochem 2002; 82:283 - 294
   PubMed Web of Science ®Google Scholar
• Lu DC, Soriano S, Bredesen DE, Koo EH. Caspase cleavage of the amyloid precursor protein modulates amyloid β-protein toxicity. J Neurochem 2003; 87:733 - 741
   PubMed Web of Science ®Google Scholar
• Park HJ, Kim SS, Seong YM, Kim KH, Goo HG, Yoon EJ, et al. Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. J Biol Chem 2006; 281:34277 - 34287
   PubMed Web of Science ®Google Scholar
• Tanzi RE, Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005; 120:545 - 555
   PubMed Web of Science ®Google Scholar
• Ertekin-Taner N. Genetics of Alzheimer's disease: a centennial review. Neurol Clin 2007; 25:611 - 667
   PubMed Web of Science ®Google Scholar
• Kowalska A. Amyloid precursor protein gene mutations responsible for early-onset autosomal dominant Alzheimer's disease. Folia Neuropathol 2003; 41:35 - 40
   PubMedGoogle Scholar
• Czech C, Tremp G, Pradier L. Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms. Prog Neurobiol 2000; 60:363 - 384
   PubMed Web of Science ®Google Scholar
• Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 1996; 383:710 - 713
   PubMed Web of Science ®Google Scholar
• Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 1997; 3:67 - 72
   PubMed Web of Science ®Google Scholar
• Huang Y, Weisgraber KH, Mucke L, Mahley RW. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J Mol Neurosci 2004; 23:189 - 204
   PubMed Web of Science ®Google Scholar
• Poirier J. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease. Neurobiol Aging 2005; 26:355 - 361
   PubMed Web of Science ®Google Scholar
• Sambamurti K, Granholm AC, Kindy MS, Bhat NR, Greig NH, Lahiri DK, et al. Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors. Curr Drug Targets 2004; 5:517 - 528
   PubMed Web of Science ®Google Scholar
• Sjogren M, Mielke M, Gustafson D, Zandi P, Skoog I. Cholesterol and Alzheimer's disease- is there a relation?. Mech Ageing Dev 2006; 127:138 - 147
   PubMed Web of Science ®Google Scholar
• Whitfield JF. Can statins put the brakes on Alzheimer's disease?. Expert Opin Investig Drugs 2006; 15:1479 - 1485
   PubMed Web of Science ®Google Scholar
• Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007; 39:168 - 177
   PubMed Web of Science ®Google Scholar
• Tang BL, Liou YC. Novel modulators of amyloid-β precursor protein processing. J Neurochem 2007; 100:314 - 323
   PubMed Web of Science ®Google Scholar
• He W, Lu Y, Qahwash I, Hu XY, Chang A, Yan R. Reticulon family members modulate BACE1 activity and amyloid-β peptide generation. Nat Med 2004; 10:959 - 965
   PubMed Web of Science ®Google Scholar
• Murayama KS, Kametani F, Saito S, Kume H, Akiyama H, Araki W. Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid β-protein. Eur J Neurosci 2006; 24:1237 - 1244
   PubMed Web of Science ®Google Scholar
• Park JH, Gimbel DA, GrandPre T, Lee JK, Kim JE, Li W, et al. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-β plaque deposition. J Neurosci 2006; 26:1386 - 1395
   PubMed Web of Science ®Google Scholar
• Park JH, Widi GA, Gimbel DA, Harel NY, Lee DH, Strittmatter SM. Subcutaneous Nogo receptor removes brain amyloid-β and improves spatial memory in Alzheimer's transgenic mice. J Neurosci 2006; 26:13279 - 13286
   PubMed Web of Science ®Google Scholar
• Zhou Y, Su Y, Li B, Liu F, Ryder JW, Wu X, et al. Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Aβ42 by inhibiting Rho. Science 2003; 302:1215 - 1217
   PubMed Web of Science ®Google Scholar
• Pedrini S, Carter TL, Prendergast G, Petanceska S, Ehrlich ME, Gandy S. Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK. PLoS Med 2005; 2:18
   PubMed Web of Science ®Google Scholar
• Gianni D, Zambrano N, Bimonte M, Minopoli G, Mercken L, Talamo F, et al. Platelet-derived growth factor induces the beta-gamma-secretase-mediated cleavage of Alzheimer's amyloid precursor protein through a Src-Rac-dependent pathway. J Biol Chem 2003; 278:9290 - 9297
   PubMed Web of Science ®Google Scholar
• Pastorino L, Sun A, Lu PJ, Zhou XZ, Balastik M, Finn G, et al. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production. Nature 2006; 440:528 - 534
   PubMed Web of Science ®Google Scholar
• Bishop GM, Robinson SR. The amyloid paradox: amyloid-beta-metal complexes can be neurotoxic and neuroprotective. Brain Pathol 2004; 14:448 - 452
   PubMed Web of Science ®Google Scholar
• Adlard PA, Bush AI. Metals and Alzheimer's disease. J Alzheimer's Dis 2006; 10:145 - 163
   PubMed Web of Science ®Google Scholar
• Smith DG, Cappai R, Barnham KJ. The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim Biophys Acta 2007; 1768:1976 - 1990
   PubMed Web of Science ®Google Scholar
• Reddy PH. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J Neurochem 2006; 96:1 - 13
   PubMed Web of Science ®Google Scholar
• Zhu X, Su B, Wang X, Smith MA, Perry G. Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 2007; 64:2202 - 2210
   PubMed Web of Science ®Google Scholar
• Small SA, Gandy S. Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis. Neuron 2006; 52:15 - 31
   PubMed Web of Science ®Google Scholar
• Pasternak SH, Callahan JW, Mahuran DJ. The role of the endosomal/lysosomal system in amyloid-β production and the pathophysiology of Alzheimer's disease: reexamining the spatial paradox from a lysosomal perspective. J Alzheimer's Dis 2004; 6:53 - 65
   PubMed Web of Science ®Google Scholar
• Lee EB, Zhang B, Liu K, Greenbaum EA, Doms RW, Trojanowski JQ, et al. BACE1 overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo. J Cell Biol 2005; 168:291 - 302
   PubMed Web of Science ®Google Scholar
• Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, et al. Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 2003; 9:3 - 4
   PubMed Web of Science ®Google Scholar
• Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, et al. Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci USA 2004; 101:3632 - 3637
   PubMed Web of Science ®Google Scholar
• Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, et al. BACE1 knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet 2001; 10:1317 - 1324
   PubMed Web of Science ®Google Scholar
• Vassar R. Beta-secretase (BACE1) as a drug target for Alzheimer's disease. Adv Drug Deliv Rev 2002; 54:1589 - 1602
   PubMed Web of Science ®Google Scholar
• Durham TB, Shepherd TA. Progress toward the discovery and development of efficacious BACE1 inhibitors. Curr Opin Drug Discov Devel 2006; 9:776 - 791
   PubMed Web of Science ®Google Scholar
• Koo EH, Squazzo SL. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 1994; 269:17386 - 17389
   PubMed Web of Science ®Google Scholar
• Tate BA, Mathews PM. Targeting the role of the endosome in the pathophysiology of Alzheimer's disease: a strategy for treatment. Sci Aging Knowledge Environ 2006; 2006:2
   Google Scholar
• Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W, Selkoe DJ, et al. Mutagenesis identifies new signals for β-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Aβ42. J Biol Chem 1999; 274:18851 - 18856
   PubMed Web of Science ®Google Scholar
• Grbovic OM, Mathews PM, Jiang Y, Schmidt SD, Dinakar R, Summers-Terio NB, et al. Rab5-stimulated upregulation of the endocytic pathway increases intracellular β-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Aβ production. J Biol Chem 2003; 278:31261 - 31268
   PubMed Web of Science ®Google Scholar
• Carey RM, Balcz BA, Lopez-Coviella I, Slack BE. Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid β protein. BMC Cell Biol 2005; 6:30
   PubMed Web of Science ®Google Scholar
• Huse JT, Pijak DS, Leslie GJ, Lee VM, Doms RW. Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme, the Alzheimer's disease β-secretase. J Biol Chem 2000; 275:33729 - 33737
   PubMed Web of Science ®Google Scholar
• Kinoshita A, Fukumoto H, Shah T, Whelan CM, Irizarry MC, Hyman BT. Demonstration by FRET of BACE1 interaction with the amyloid precursor protein at the cell surface and in early endosomes. J Cell Sci 2003; 116:3339 - 3346
   PubMed Web of Science ®Google Scholar
• Ermolieff J, Loy JA, Koelsch G, Tang J. Proteolytic activation of recombinant promemapsin 2 (pro-β-secretase) studied with new fluorogenic substrates. Biochemistry 2000; 39:12450 - 12456
   PubMed Web of Science ®Google Scholar
• De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998; 391:387 - 390
   PubMed Web of Science ®Google Scholar
• Li YM, Xu M, Lai MT, Huang Q, Castro JL, DiMuzio-Mower J, et al. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 2000; 405:689 - 694
   PubMed Web of Science ®Google Scholar
• Kovacs DM, Fausett HJ, Page KJ, Kim TW, Moir RD, Merriam DE, et al. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med 1996; 2:224 - 229
   PubMed Web of Science ®Google Scholar
• Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, Westaway D, et al. Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. J Cell Biol 1999; 147:277 - 294
   PubMed Web of Science ®Google Scholar
• Kaether C, Haass C, Steiner H. Assembly, trafficking and function of γ-secretase. Neurodegener Dis 2006; 3:275 - 283
   PubMed Web of Science ®Google Scholar
• Kim J, Kleizen B, Choy R, Thinakaran G, Sisodia SS, Schekman RW. Biogenesis of γ-secretase early in the secretory pathway. J Cell Biol 2007; 179:951 - 963
   PubMed Web of Science ®Google Scholar
• Hansson CA, Frykman S, Farmery MR, Tjernberg LO, Nilsberth C, Pursglove SE, et al. Nicastrin, presenilin, APH-1, and PEN-2 form active γ-secretase complexes in mitochondria. J Biol Chem 2004; 279:51654 - 51660
   PubMed Web of Science ®Google Scholar
• Kaether C, Schmitt S, Willem M, Haass C. Amyloid precursor protein and Notch intracellular domains are generated after transport of their precursors to the cell surface. Traffic 2006; 7:408 - 415
   PubMed Web of Science ®Google Scholar
• Naruse S, Thinakaran G, Luo JJ, Kusiak JW, Tomita T, Iwatsubo T, et al. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 1998; 21:1213 - 1221
   PubMed Web of Science ®Google Scholar
• Cai D, Leem JY, Greenfield JP, Wang P, Kim BS, Wang R, et al. Presenilin-1 regulates intracellular trafficking and cell surface delivery of β-amyloid precursor protein. J Biol Chem 2003; 278:3446 - 3454
   PubMed Web of Science ®Google Scholar
• Cai D, Netzer WJ, Zhong M, Lin Y, Du G, Frohman M, et al. Presenilin-1 uses phospholipase D1 as a negative regulator of β-amyloid formation. Proc Natl Acad Sci USA 2006; 103:1941 - 1946
   PubMed Web of Science ®Google Scholar
• Cai D, Zhong M, Wang R, Netzer WJ, Shields D, Zheng H, et al. Phospholipase D1 corrects impaired βAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proc Natl Acad Sci USA 2006; 103:1936 - 1940
   PubMed Web of Science ®Google Scholar
• Zhang M, Haapasalo A, Kim DY, Ingano LA, Pettingell WH, Kovacs DM. Presenilin/γ-secretase activity regulates protein clearance from the endocytic recycling compartment. FASEB J 2006; 20:1176 - 1178
   PubMed Web of Science ®Google Scholar
• Rossner S, Apelt J, Schliebs R, Perez-Polo JR, Bigl V. Neuronal and glial β-secretase (BACE1) protein expression in transgenic Tg2576 mice with amyloid plaque pathology. J Neurosci Res 2001; 64:437 - 446
   PubMed Web of Science ®Google Scholar
• Tang BL. Emerging aspects of membrane traffic in neuronal dendrite growth. Biochim Biophys Acta 2008; 1783:169 - 176
   PubMed Web of Science ®Google Scholar
• Tang BL. Alzheimer's disease: channeling APP to non-amyloidogenic processing. Biochem Biophys Res Commun 2005; 331:375 - 378
   PubMed Web of Science ®Google Scholar
• Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, et al. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci USA 1999; 96:3922 - 3927
   PubMed Web of Science ®Google Scholar
• Skovronsky DM, Moore DB, Milla ME, Doms RW, Lee VM. Protein kinase C-dependent α-secretase competes with β-secretase for cleavage of amyloid-β precursor protein in the trans-Golgi network. J Biol Chem 2000; 275:2568 - 2575
   PubMed Web of Science ®Google Scholar
• Haass C, Koo EH, Teplow DB, Selkoe DJ. Polarized secretion of β-amyloid precursor protein and amyloid β-peptide in MDCK cells. Proc Natl Acad Sci USA 1994; 91:1564 - 1568
   PubMed Web of Science ®Google Scholar
• Capell A, Meyn L, Fluhrer R, Teplow DB, Walter J, Haass C. Apical sorting of β-secretase limits amyloid β-peptide production. J Biol Chem 2002; 277:5637 - 5643
   PubMed Web of Science ®Google Scholar
• Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K, et al. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA 1990; 87:1561 - 1565
   PubMed Web of Science ®Google Scholar
• Simons M, Ikonen E, Tienari PJ, Cid-Arregui A, Mönning U, Beyreuther K, et al. Intracellular routing of human amyloid protein precursor: axonal delivery followed by transport to the dendrites. J Neurosci Res 1995; 41:121 - 128
   PubMed Web of Science ®Google Scholar
• Back S, Haas P, Tschäpe JA, Gruebl T, Kirsch J, Müller U, et al. β-amyloid precursor protein can be transported independent of any sorting signal to the axonal and dendritic compartment. J Neurosci Res 2007; 85:2580 - 2590
   PubMed Web of Science ®Google Scholar
• Beher D, Elle C, Underwood J, Davis JB, Ward R, Karran E, et al. Proteolytic fragments of Alzheimer's disease-associated presenilin 1 are present in synaptic organelles and growth cone membranes of rat brain. J Neurochem 1999; 72:1564 - 1573
   PubMed Web of Science ®Google Scholar
• Icking A, Amaddii M, Ruonala M, Höning S, Tikkanen R. Polarized transport of Alzheimer amyloid precursor protein is mediated by adaptor protein complex AP1-1B. Traffic 2007; 8:285 - 296
   PubMed Web of Science ®Google Scholar
• Bonifacino JS. The GGA proteins: adaptors on the move. Nat Rev Mol Cell Biol 2004; 5:23 - 32
   PubMedGoogle Scholar
• Von Arnim CA, Spoelgen R, Peltan ID, Deng M, Courchesne S, Koker M, et al. GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing. J Neurosci 2006; 26:9913 - 9922
   PubMed Web of Science ®Google Scholar
• Wahle T, Thal DR, Sastre M, Rentmeister A, Bogdanovic N, Famulok M. GGA1 is expressed in the human brain and affects the generation of amyloid β-peptide. J Neurosci 2006; 26:12838 - 12846
   PubMed Web of Science ®Google Scholar
• Tesco G, Koh YH, Kang EL, Cameron AN, Das S, Sena-Esteves M, et al. Depletion of GGA3 stabilizes BACE1 and enhances beta-secretase activity. Neuron 2007; 54:721 - 737
   PubMed Web of Science ®Google Scholar
• Seman MN. Recycle your receptors with retromer. Trends Cell Biol 2005; 15:68 - 75
   PubMed Web of Science ®Google Scholar
• He X, Li F, Chang WP, Tang J. GGA proteins mediate the recycling pathway of memapsin 2 (BACE1). J Biol Chem 2005; 280:11696 - 11703
   PubMed Web of Science ®Google Scholar
• Small SA, Kent K, Pierce A, Leung C, Kang MS, Okada H, et al. Model-guided microarray implicates the retromer complex in Alzheimer's disease. Ann Neurol 2005; 58:909 - 919
   PubMed Web of Science ®Google Scholar
• Riemenschneider M, Schoepfer-Wendels A, Friedrich P, Konta L, Laws SM, Mueller JC, et al. No association of vacuolar protein sorting 26 polymorphisms with Alzheimer's disease. Neurobiol Aging 2007; 28:883 - 884
   PubMed Web of Science ®Google Scholar
• Dugan JM, DeWit C, McConlogue L, Maltese WA. The Ras-related GTP-binding protein, Rab1B, regulates early steps in exocytic transport and processing of beta-amyloid precursor protein. J Biol Chem 1995; 270:10982 - 10989
   PubMed Web of Science ®Google Scholar
• McConlogue L, Castellano F, DeWit C, Schenk D, Maltese WA. Differential effects of a Rab6 mutant on secretory versus amyloidogenic processing of Alzheimer's beta-amyloid precursor protein. J Biol Chem 1996; 271:1343 - 1348
   PubMed Web of Science ®Google Scholar
• Wang Y, Tang BL. SNAREs in neurons—beyond synaptic vesicle exocytosis. Mol Membr Biol 2006; 23:377 - 384
   PubMed Web of Science ®Google Scholar
• Kawasumi M, Matsuda S, Matsuoka M, Nishimoto I. Cytoplasmic tail adaptors of Alzheimer's amyloid-β protein precursor. Mol Neurobiol 2004; 30:185 - 200
   PubMed Web of Science ®Google Scholar
• Russo C, Venezia V, Repetto E, Nizzari M, Violani E, Carlo P, Schettini G. The amyloid precursor protein and its network of interacting proteins: physiological and pathological implications. Brain Res Rev 2005; 48:257 - 264
   PubMed Web of Science ®Google Scholar
• Miller CC, McLoughlin DM, Lau KF, Tennant ME, Rogelj B. The X11 proteins, Aβ production and Alzheimer's disease. Trends Neurosci 2006; 29:280 - 285
   PubMed Web of Science ®Google Scholar
• He X, Cooley K, Chung CH, Dashti N, Tang J. Apolipoprotein receptor 2 and X11 α/β mediate apolipoprotein E-induced endocytosis of amyloid-β precursor protein and β-secretase, leading to amyloid-beta production. J Neurosci 2007; 27:4052 - 4060
   PubMed Web of Science ®Google Scholar
• Shrivastava-Ranjan P, Faundez V, Fang G, Rees H, Lah JJ, Levey AI. Mint3/X11γ is an ADP-ribosylation factor-dependent adaptor that regulates the traffic of the Alzheimer's precursor protein from the Trans-Golgi network. Mol Biol Cell 2008; 19:51 - 64
   PubMed Web of Science ®Google Scholar
• Hoe HS, Tran TS, Matsuoka Y, Howell BW, Rebeck GW. DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing. J Biol Chem 2006; 281:35176 - 35185
   PubMed Web of Science ®Google Scholar
• Parisiadou L, Efthimiopoulos S. Expression of mDab1 promotes the stability and processing of amyloid precursor protein and this effect is counteracted by X11α. Neurobiol Aging 2007; 28:377 - 388
   PubMed Web of Science ®Google Scholar
• McLoughlin DM, Miller CC. The Fe65 proteins and Alzheimer's disease. J Neurosci Res 2008; 86:744 - 754
   PubMed Web of Science ®Google Scholar
• Hoe HS, Magill LA, Guenette S, Fu Z, Vicini S, Rebeck GW. Fe65 interaction with the ApoE receptor ApoEr2. J Biol Chem 2006; 281:24521 - 24530
   PubMed Web of Science ®Google Scholar
• Wiley JC, Smith EA, Hudson MP, Ladiges WC, Bothwell M. Fe65 stimulates proteolytic liberation of the β-amyloid precursor protein intracellular domain. J Biol Chem 2007; 282:33313 - 33325
   PubMed Web of Science ®Google Scholar
• Matsuda S, Yasukawa T, Homma Y, Ito Y, Niikura T, Hiraki T, et al. c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK. J Neurosci 2001; 21:6597 - 6607
   PubMed Web of Science ®Google Scholar
• Inomata H, Nakamura Y, Hayakawa A, Takata H, Suzuki T, Miyazawa K, et al. A scaffold protein JIP-1b enhances amyloid precursor protein phosphorylation by JNK and its association with kinesin light chain 1. J Biol Chem 2003; 278:22946 - 22955
   PubMed Web of Science ®Google Scholar
• Horiuchi D, Collins CA, Bhat P, Barkus RV, Diantonio A, Saxton WM. Control of a kinesin-cargo linkage mechanism by JNK pathway kinases. Curr Biol 2007; 17:1313 - 1317
   PubMed Web of Science ®Google Scholar
• Harris-White ME, Frautschy SA. Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition. Curr Drug Targets CNS Neurol Disord 2005; 4:469 - 480
   PubMedGoogle Scholar
• Waldron E, Jaeger S, Pietrzik CU. Functional role of the low-density lipoprotein receptor-related protein in Alzheimer's disease. Neurodegener Dis 2006; 3:233 - 238
   PubMed Web of Science ®Google Scholar
• Cam JA, Bu G. Modulation of β-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family. Mol Neurodegener 2006; 18:1 - 8
   Google Scholar
• Liu Q, Zerbinatti CV, Zhang J, Hoe HS, Wang B, Cole SL, et al. Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 2007; 56:66 - 78
   PubMed Web of Science ®Google Scholar
• Cam JA, Zerbinatti CV, Knisely JM, Hecimovic S, Li Y, Bu G. The low density lipoprotein receptor-related protein 1B retains beta-amyloid precursor protein at the cell surface and reduces amyloid-beta peptide production. J Biol Chem 2004; 279:29639 - 29646
   PubMed Web of Science ®Google Scholar
• Dodson SE, Gearing M, Lippa CF, Montine TJ, Levey AI, Lah JJ. LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J Neuropathol Exp Neurol 2006; 65:866 - 872
   PubMed Web of Science ®Google Scholar
• Spoelgen R, Von Arnim CA, Thomas AV, Peltan ID, Koker M, Deng A, et al. Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and β-secretase beta-site APP-cleaving enzyme. J Neurosci 2006; 26:418 - 428
   PubMed Web of Science ®Google Scholar
• Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, et al. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci USA 2005; 102:13461 - 13466
   PubMed Web of Science ®Google Scholar
• Offe K, Dodson SE, Shoemaker JT, Fritz JJ, Gearing M, Levey AI. The lipoprotein receptor LR11 regulates amyloid β production and amyloid precursor protein traffic in endosomal compartments. J Neurosci 2006; 26:1596 - 1603
   PubMed Web of Science ®Google Scholar
• Schmidt V, Sporbert A, Rohe M, Reimer T, Rehm A, Andersen OM, et al. SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1. J Biol Chem 2007; 282:32956 - 32964
   PubMedGoogle Scholar
• Sager KL, Wuu J, Leurgans SE, Rees HD, Gearing M, Mufson EJ, et al. Neuronal LR11/sorLA expression is reduced in mild cognitive impairment. Ann Neurol 2007; 62:640 - 647
   PubMed Web of Science ®Google Scholar
• Ma QL, Teter B, Ubeda OJ, Morihara T, Dhoot D, Nyby MD, et al. Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention. J Neurosci 2007; 27:14299 - 14307
   PubMed Web of Science ®Google Scholar
• Bertram L, Hiltunen M, Parkinson M, Ingelsson M, Lange C, Ramasamy K, et al. Family-based association between Alzheimer's disease and variants in UBQLN1. N Engl J Med 2005; 352:884 - 894
   PubMed Web of Science ®Google Scholar
• Hiltunen M, Lu A, Thomas AV, Romano DM, Kim M, Jones PB, et al. Ubiquilin 1 modulates amyloid precursor protein trafficking and Aβ secretion. J Biol Chem 2006; 281:32240 - 32253
   PubMed Web of Science ®Google Scholar
• Zheng P, Eastman J, Vande Pol S, Pimplikar SW. PAT1, a microtubule-interacting protein, recognizes the basolateral sorting signal of amyloid precursor protein. Proc Natl Acad Sci USA 1998; 95:14745 - 14750
   PubMed Web of Science ®Google Scholar
• Kuan YH, Gruebl T, Soba P, Eggert S, Nesic I, Back S, et al. PAT1a modulates intracellular transport and processing of amyloid precursor protein (APP), APLP1, and APLP2. J Biol Chem 2006; 281:40114 - 40123
   PubMed Web of Science ®Google Scholar
• Vetrivel KS, Gong P, Bowen JW, Cheng H, Chen Y, Carter M, et al. Dual roles of the transmembrane protein p23/TMP21 in the modulation of amyloid precursor protein metabolism. Mol Neurodegener 2007; 2:4
   PubMed Web of Science ®Google Scholar
• Hirokawa N, Takemura R. Molecular motors and mechanisms of directional transport in neurons. Nat Rev Neurosci 2005; 6:201 - 214
   PubMed Web of Science ®Google Scholar
• Roy S, Zhang B, Lee VM, Trojanowski JQ. Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol 2005; 109:5 - 13
   PubMed Web of Science ®Google Scholar
• Chevalier-Larsen E, Holzbaur EL. Axonal transport and neurodegenerative disease. Biochim Biophys Acta 2006; 1762:1094 - 1108
   PubMed Web of Science ®Google Scholar
• El-Kadi AM, Soura V, Hafezparast M. Defective axonal transport in motor neuron disease. J Neurosci Res 2007; 85:2557 - 2566
   PubMed Web of Science ®Google Scholar
• Münch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A, et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 2004; 63:724 - 726
   PubMed Web of Science ®Google Scholar
• Trushina E, Dyer RB, Badger JD 2nd, Ure D, Eide L, Tran DD, et al. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 2004; 24:8195 - 8209
   PubMed Web of Science ®Google Scholar
• Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1β. Cell 2001; 105:587 - 597
   PubMed Web of Science ®Google Scholar
• Meggouh F, Bienfait HM, Weterman MA, De Visser M, Baas F. Charcot-Marie-Tooth disease due to a de novo mutation of the RAB7 gene. Neurology 2006; 67:1476 - 1478
   PubMed Web of Science ®Google Scholar
• Brownlees J, Ackerley S, Grierson AJ, Jacobsen NJ, Shea K, Anderton BH, et al. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum Mol Genet 2002; 11:2837 - 2844
   PubMed Web of Science ®Google Scholar
• Dickson TC, Vickers JC. The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience 2001; 105:99 - 107
   PubMed Web of Science ®Google Scholar
• Spires TL, Hyman BT. Neuronal structure is altered by amyloid plaques. Rev Neurosci 2004; 15:267 - 278
   PubMed Web of Science ®Google Scholar
• Munoz DG, Wang D. Tangle-associated neuritic clusters. A new lesion in Alzheimer's disease and aging suggests that aggregates of dystrophic neurites are not necessarily associated with β/A4. Am J Pathol 1992; 140:1167 - 1178
   PubMed Web of Science ®Google Scholar
• Tabaton M, Mandybur TI, Perry G, Onorato M, Autilio-Gambetti L, Gambetti P. The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition. Ann Neurol 1989; 26:771 - 778
   PubMed Web of Science ®Google Scholar
• Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005; 307:1282 - 1288
   PubMed Web of Science ®Google Scholar
• Rockenstein E, Mante M, Alford M, Adame A, Crews L, Hashimoto M, et al. High β-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-β levels: implications for the treatment of Alzheimer disease. J Biol Chem 2005; 280:32957 - 32967
   PubMed Web of Science ®Google Scholar
• Lazarov O, Morfini GA, Pigino G, Gadadhar A, Chen X, Robinson J, et al. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J Neurosci 2007; 27:7011 - 7020
   PubMed Web of Science ®Google Scholar
• Wirths O, Weis J, Szczygielski J, Multhaup G, Bayer TA. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Acta Neuropathol 2006; 111:312 - 319
   PubMed Web of Science ®Google Scholar
• Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, Laenen I, et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 1999; 155:2153 - 2165
   PubMed Web of Science ®Google Scholar
• Leroy K, Bretteville A, Schindowski K, Gilissen E, Authelet M, De Decker R, et al. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Am J Pathol 2007; 171:976 - 992
   PubMed Web of Science ®Google Scholar
• Tesseur I, Van Dorpe J, Bruynseels K, Bronfman F, Sciot R, Van Lommel A, et al. Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am J Pathol 2000; 157:1495 - 1510
   PubMed Web of Science ®Google Scholar
• Torroja L, Chu H, Kotovsky I, White K. Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport. Curr Biol 1999; 9:489 - 492
   PubMed Web of Science ®Google Scholar
• Medina D, DeToledo-Morrell L, Urresta F, Gabrieli JD, Moseley M, Fleischman D, et al. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging 27:663 - 672
   PubMed Web of Science ®Google Scholar
• Van Es AC, Van der Flier WM, Admiraal-Behloul F, Olofsen H, Bollen EL, Middelkoop HA, et al. Magnetization transfer imaging of gray and white matter in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2006; 27:1757 - 1762
   PubMed Web of Science ®Google Scholar
• Kins S, Lauther N, Szodorai A, Beyreuther K. Subcellular trafficking of the amyloid precursor protein gene family and its pathogenic role in Alzheimer's disease. Neurodegener Dis 2006; 3:218 - 226
   PubMed Web of Science ®Google Scholar
• Walter J. Control of amyloid-β-peptide generation by subcellular trafficking of the betaamyloid precursor protein and β-secretase. Neurodegener Dis 2006; 3:247 - 254
   PubMed Web of Science ®Google Scholar
• Lazarov O, Lee M, Peterson DA, Sisodia SS. Evidence that synaptically released betaamyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci 2002; 22:9785 - 9793
   PubMed Web of Science ®Google Scholar
• Kamal A, Stokin GB, Yang Z, Xia CH, Goldstein LS. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 2000; 28:449 - 459
   PubMed Web of Science ®Google Scholar
• Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 2001; 414:643 - 648
   PubMed Web of Science ®Google Scholar
• Lazarov O, Morfini GA, Lee EB, Farah MH, Szodorai A, et al. Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J Neurosci 2005; 25:2386 - 2395
   PubMed Web of Science ®Google Scholar
• Chen XH, Siman R, Iwata A, Meaney DF, Trojanowski JQ, Smith DH. Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma. Am J Pathol 2004; 165:357 - 371
   PubMed Web of Science ®Google Scholar
• Uryu K, Chen XH, Martinez D, Browne KD, Johnson VE, Graham DI, et al. Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp Neurol 2007; 208:185 - 192
   PubMed Web of Science ®Google Scholar
• Stone JR, Okonkwo DO, Dialo AO, Rubin DG, Mutlu LK, Povlishock JT, et al. Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury. Exp Neurol 2004; 190:59 - 69
   PubMed Web of Science ®Google Scholar
• Smith DH, Uryu K, Saatman KE, Trojanowski JQ, McIntosh TK. Protein accumulation in traumatic brain injury. Neuromolecular Med 2003; 4:59 - 72
   PubMed Web of Science ®Google Scholar
• Utton MA, Noble WJ, Hill JE, Anderton BH, Hanger DP. Molecular motors implicated in the axonal transport of tau and α-synuclein. J Cell Sci 2005; 118:4645 - 4654
   PubMed Web of Science ®Google Scholar
• Johnson GV, Stoothoff WH. Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci 2004; 117:5721 - 5729
   PubMed Web of Science ®Google Scholar
• Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 2002; 156:1051 - 1063
   PubMed Web of Science ®Google Scholar
• Mandelkow EM, Stamer K, Vogel R, Thies E, Mandelkow E. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging 2003; 24:1079 - 1085
   PubMed Web of Science ®Google Scholar
• Magnani E, Fan J, Gasparini L, Golding M, Williams M, Schiavo G, et al. Interaction of tau protein with the dynactin complex. EMBO J 26:4546 - 4554
   PubMed Web of Science ®Google Scholar
• Zheng WH, Bastianetto S, Mennicken F, Ma W, Kar S. Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 2002; 115:201 - 211
   PubMed Web of Science ®Google Scholar
• De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, Lacor PN, et al. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers. Neurobiol Aging 2008; 29:1334 - 1347
   PubMed Web of Science ®Google Scholar
• Terwel D, Dewachter I, Van Leuven F. Axonal transport, tau protein and neurodegeneration in Alzheimer's disease. Neuromolecular Med 2002; 2:151 - 165
   PubMed Web of Science ®Google Scholar
• Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM. Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 2004; 43:321 - 332
   PubMed Web of Science ®Google Scholar
• Cruz JC, Tsai LH. Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol Med 2004; 10:452 - 458
   PubMed Web of Science ®Google Scholar
• Cruz JC, Kim D, Moy LY, Dobbin MM, Sun X, Bronson RT, Tsai LH. p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid β in vivo. J Neurosci 2006; 26:10536 - 10541
   PubMed Web of Science ®Google Scholar
• Stokin GB, Goldstein LS. Axonal transport and Alzheimer's disease. Annu Rev Biochem 2006; 75:607 - 627
   PubMed Web of Science ®Google Scholar
• Leuner K, Hauptmann S, Abdel-Kader R, Scherping I, Keil U, Strosznajder JB, et al. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?. Antioxid Redox Signal 2007; 9:1659 - 1675
   PubMed Web of Science ®Google Scholar
• Coleman M. Axon degeneration mechanisms: Commonality amid diversity. Nat Rev Neurosci 2005; 6:889 - 898
   PubMed Web of Science ®Google Scholar
• Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, et al. Aβ oligomerinduced aberrations in synapse composition, shape and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 2007; 27:796 - 807
   PubMed Web of Science ®Google Scholar
• Calabrese B, Shaked GM, Tabarean IV, Braga J, Koo EH, Halpain S. Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-beta protein. Mol Cell Neurosci 2007; 35:183 - 193
   PubMed Web of Science ®Google Scholar
• Nimmrich V, Grimm C, Draguhn A, Barghorn S, Lehmann A, Schoemaker H, et al. Amyloid beta oligomers (Aβ(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J Neurosci 2008; 28:788 - 797
   PubMed Web of Science ®Google Scholar
• Kelly BL, Ferreira A. Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. Neuroscience 2007; 147:60 - 70
   PubMed Web of Science ®Google Scholar
• Rowan MJ, Klyubin I, Wang Q, Hu NW, Anwyl R. Synaptic memory mechanisms: Alzheimer's disease amyloid β-peptide-induced dysfunction. Biochem Soc Trans 2007; 35:1219 - 1223
   PubMed Web of Science ®Google Scholar
• Ting JT, Kelley BG, Lambert TJ, Cook DG, Sullivan JM. Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms. Proc Natl Acad Sci USA 2007; 104:353 - 358
   PubMed Web of Science ®Google Scholar
• Chen QS, Kagan BL, Hirakura Y, Xie CW. Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res 2000; 60:65 - 72
   PubMed Web of Science ®Google Scholar
• Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002; 416:535 - 539
   PubMed Web of Science ®Google Scholar
• Shepherd JD, Huganir RL. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol 2007; 23:613 - 643
   PubMed Web of Science ®Google Scholar
• Greger IH, Esteban JA. AMPA receptor biogenesis and trafficking. Curr Opin Neurobiol 2007; 17:289 - 297
   PubMed Web of Science ®Google Scholar
• Parameshwaran K, Sims C, Kanju P, Vaithianathan T, Shonesy BC, Dhanasekaran M, et al. Amyloid beta-peptide Aβ(1–42) but not Aβ(1–40) attenuates synaptic AMPA receptor function. Synapse 2007; 61:367 - 374
   PubMed Web of Science ®Google Scholar
• Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 2006; 52:831 - 843
   PubMed Web of Science ®Google Scholar
• Kamenatz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, et al. APP processing and synaptic function. Neuron 2003; 37:925 - 937
   PubMed Web of Science ®Google Scholar
• Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007; 27:2866 - 2875
   PubMed Web of Science ®Google Scholar
• Pérez-Otaño I, Ehlers MD. Homeostatic plasticity and NMDA receptor trafficking. Trends Neurosci 2005; 28:229 - 238
   PubMed Web of Science ®Google Scholar
• Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, et al. Regulation of NMDA receptor trafficking by amyloid-β. Nat Neurosci 2005; 8:1051 - 1058
   PubMed Web of Science ®Google Scholar
• Tanzi RE. The synaptic Abeta hypothesis of Alzheimer disease. Nat Neurosci 2005; 8:977 - 979
   PubMed Web of Science ®Google Scholar